Membrane type-matrix metalloproteinases (MT-MMP)

https://doi.org/10.1016/S0070-2153(03)54004-2Get rights and content

Publisher Summary

Matrix metalloproteinases (MMPs) belong to the family of zinc endopeptidases collectively referred to as metzincins. The metzincin superfamily is distinguished by a highly conserved motif containing three histidines that bind zinc at the catalytic site and a conserved methionine that sits beneath the active site. The metzincins are subdivided into four multigene families: serralysins, astacins, ADAMs/adamalysins, and MMPs. Once activated, MMPs degrade a variety of extracellular matrix components and assorted other proteins including growth factors, growth factor binding proteins, and protease inhibitors. The ability to degrade extracellular matrix proteins is essential for any cell to interact properly with its immediate surroundings and for multicellular organisms to develop and function normally. MMPs also generate matrix protein fragments, which have functional activity of their own. These various functions of MMPs modulate cell invasion and metastasis, cell migration, apoptosis, and angiogenesis. The belief that an MMP is involved in a given biologic/pathologic process is often based on the strength of its association with that process and the existence of plausible mechanisms that can be tested by experimental approaches. Because of extensive redundancy of MMP function in animals, it has been difficult to appreciate the role of individual genes in various experimental models. The multiplicity of MMPs with distinct but somewhat overlapping functions appears to act as a safeguard against loss of regulatory control. The known MMP genes have been divided into four subfamilies based on gene structure. Group I consists of the collagenase subfamily. Group 2 consists of the gelatinases/modular alteration (fimodular a-like domains) subfamily. Group 3 consists of the variant hemopexin exon subfamily. Group 4 consists of the variant catalytic exon and unique 3′-end exon (plasma membrane and cytoplasmic domains) subfamily, which consists of the membrane type-matrix metalloproteinases (MT-MMPs).

References (359)

  • K Brew et al.

    Tissue inhibitors of metalloproteinases: evolution, structure and function

    Biochim. Biophys. Acta

    (2000)
  • P.C Brooks et al.

    Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin avb3

    Cell

    (1996)
  • G.S Butler et al.

    The TIMP-2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficiency of progelatinase A. A kinetic study

    J. Biol. Chem.

    (1998)
  • J Cao et al.

    The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation

    J. Biol. Chem.

    (1995)
  • J Cao et al.

    Membrane type matrix metalloproteinase 1 (MT-MMP1) activates progelatinase A without furin cleavage of the N-terminal domain

    J. Biol. Chem.

    (1996)
  • J Cao et al.

    The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells

    J. Biol. Chem.

    (2000)
  • J.J Caterina et al.

    Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (Timp-2) gene alters proMMP-2 activation

    J. Biol. Chem.

    (2000)
  • V Chiarugi et al.

    Tumor angiogenesis: thrombin and metalloproteinases in focus

    Exp. Mol. Pathol.

    (2000)
  • M.-P d'Ortho et al.

    MT1-MMP on the cell surface causes focal degradation of gelatin films

    FEBS Lett.

    (1998)
  • B Davidson et al.

    MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization

    Gyn. Oncol.

    (1999)
  • G.E Davis

    Affinity of integrins for damaged extracellular-matrix: alpha-v-beta-3 binds to denatured collagen type-1 through RGD sites

    Biochem. Biophys. Res. Commun.

    (1992)
  • E.I Deryugina et al.

    MT1-MMP initiates activation of pro-MMP-2 and integrin avb3 promotes maturation of MMP-2 in breast carcinoma cells

    Exp. Cell Res.

    (2001)
  • E El Fahime et al.

    In vivo migration of transplanted myoblasts require matrix metalloproteinase activity

    Exp. Cell Res.

    (2000)
  • V Ellis et al.

    Cellular strategies for proteolytic targeting during migration and invasion

    FEBS Lett.

    (2001)
  • W.R English et al.

    Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-a convertase activity but does not activate pro-MMP2

    J. Biol. Chem.

    (2000)
  • W.R English et al.

    Characterization of the role of the “MT-loop”

  • W.R English et al.

    Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25)

    FEBS Lett.

    (2001)
  • A.J Fosang et al.

    Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan integlobular domain

    FEBS Lett.

    (1998)
  • Z.S Galis

    Metalloproteases in remodeling of vascular extracellular matrix

    Fibrinolysis Proteolysis

    (1999)
  • B.G Galvez et al.

    Membrane type 2-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling

    J. Biol. Chem.

    (2001)
  • D Gingras et al.

    Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism

    Biochim. Biophys. Acta

    (2000)
  • D Gingras et al.

    Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type I matrix metalloproteinase (MT1-MMP)

    FEBS Lett.

    (2001)
  • D Graesser et al.

    Distinct role for matrix metalloproteinase-2 and alpha 4 integrin in autoimmune T cell extravasation and residence in brain parenchyma during experimental autoimmune encephalitis

    J. Neuroimmunol.

    (2000)
  • G.M Grant et al.

    Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells

    Matrix Biol.

    (1999)
  • T.L Haas et al.

    Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis

    Trends Cardiovasc. Med.

    (1999)
  • T.L Haas et al.

    Three dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells

    J. Biol. Chem.

    (1998)
  • T.L Haas et al.

    Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium

    J. Biol. Chem.

    (1999)
  • T.S.A Harada et al.

    Membrane-type matrix metalloproteinase-1 (MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas

    J. Hepatol.

    (1998)
  • T.A Abbruzzese et al.

    Matrix metalloproteinase inhibition limits arterial enlargement in a rodent arteriovenous fistula model

    Surgery

    (1998)
  • M Ailenberg et al.

    Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP)

    Biochem. J.

    (1996)
  • A Anders et al.

    Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases

    FASEB J.

    (2001)
  • B Annabi et al.

    Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains

    Biochem J.

    (2001)
  • T Aoki et al.

    Two-step sandwich enzyme immunoassay using monoclonal antibodies for detection of soluble and membrane-associated human membrane type 1-matrix metalloproteinase

    J. Immunoassay Immunochem.

    (2002)
  • S Aznavoorian et al.

    Membrane type 1-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells

    Cancer Res.

    (2001)
  • H.S Azzam et al.

    Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells

    Cancer Res.

    (1992)
  • D Bassi et al.

    Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells

  • P Baumann et al.

    MT1-MMP mediated proMMP-2 activation in epidermal tumor cells

    Brit. J. Cancer

    (2000)
  • A.T.J Belien et al.

    Membrane-type 1 matrix metalloproteinase (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

    J. Cell Biol.

    (1999)
  • L Bello et al.

    Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2

    Cancer Res.

    (2001)
  • M.P Bendeck et al.

    Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury

    Circ. Res.

    (1996)
  • Cited by (0)

    View full text